BI
BioCorRx Inc.
BICX · OTC
$0.25 +0.00% (+$0.00)
1M +0.00%
Market Cap $6.60M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.29
16.0% upside
Current Price
$0.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BICX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
1 /100
Expensive P/S 8.39x
EV/FFO N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 55.06%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 401.89%
Op. margin 622.28%
FCF margin 299.44%
Quality
64 /100
Average ROA 165.74%
Asset turnover 0.41x
ROIC 92.69%
Debt
0 /100
High Int. coverage -4.19x
Current ratio 0.07x
Net debt/EBITDA N/A
Stability
19 /100
Unstable Rev. volatility 5,990.58%
EPS volatility 35.06%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BICX
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Lourdes Felix
Employees
3
Headquarters
Anaheim
Upcoming events
17 NOV
Earnings
Upcoming earnings report